First dose‐ranging study of remimazolam in Japanese patients undergoing gastrointestinal endoscopy: Phase II investigator‐initiated clinical trial
Sign Up to like & getrecommendations! Published in 2022 at "Digestive Endoscopy"
DOI: 10.1111/den.14365
Abstract: Remimazolam, an ultra‐short‐acting benzodiazepine, has been used for procedural sedation in the United States. We conducted an investigator‐initiated clinical trial to determine the appropriate dose of remimazolam required for sedation during gastrointestinal endoscopy in Japanese… read more here.
Keywords: endoscopy; gastrointestinal endoscopy; investigator initiated; clinical trial ... See more keywords